All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 6, 2023
Home » Topics » Disease categories and therapies » Infection

Infection
Infection RSS Feed RSS

Infection

Emory University describes new NHC analogues for viral infections

Dec. 22, 2022
No Comments
Emory University has identified deuterated and/or methylated N4-hydroxycytidine (NHC) analogues reported to be useful for the treatment of viral infections.
Read More
Coronavirus, mRNA and syringe
Immune

Ethris and Diosynvax collaborate to develop mRNA vaccine candidate against betacoronaviruses

Dec. 22, 2022
No Comments
Ethris GmbH has entered into a collaboration with Diosynvax Ltd. to jointly develop a protective mRNA vaccine candidate against a broad range of betacoronaviruses utilizing the company's highly differentiated mRNA modification and design technologies as well as its lipidoid nanoparticle (LNP) and stabilization platforms.
Read More
Colorized scanning electron micrograph of human respiratory syncytial virus.
Infection

Poolbeg's collaboration with Onethree Biotech identifies potential RSV drug candidates

Dec. 22, 2022
No Comments
Poolbeg Pharma plc has identified potential new drug candidates from its respiratory syncytial virus (RSV) artificial intelligence (AI) program with Onethree Biotech Inc.
Read More
Coronavirus and antibodies
Immune

RQ Bio's monoclonal antibody to prevent COVID-19 enters clinic as part of antibody combination

Dec. 22, 2022
No Comments
RQ Biotechnology Ltd. (RQ Bio) has announced that the first of its discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients, AZD-3152, has entered clinical trials.
Read More
Infection

Discovery of novel antiplasmodial compounds with promising in vivo activity

Dec. 22, 2022
No Comments
Scientists from the University of Delhi and affiliated organizations have reported the discovery and preclinical characterization of novel compounds with antiplasmodial activity.
Read More
Infection

Eurocine Vaccines’ mRNA-based HSV-2 vaccine candidate generates potent T-cell responses in preclinical studies

Dec. 21, 2022
No Comments
Eurocine Vaccines AB has reported findings from preclinical studies evaluating its mRNA and protein technology platforms for its therapeutic herpes simplex virus type 2 (HSV-2) vaccine candidates. Initial results from the study, comparing the two technology platforms at multiple doses, demonstrate that the mRNA and the protein vaccines were well tolerated and generated T-cell and antibody responses.
Read More
Women handshake with virology graphics

Pfizer opts in to rights to RSV therapy from Lianbio in a deal worth up to $155M

Dec. 20, 2022
By Doris Yu
No Comments
Pfizer Inc. has acquired rights to respiratory syncytial virus (RSV) drug candidate sisunatovir from Lianbio Co. Ltd. in a deal worth up to $155 million covering development and commercialization rights in mainland China, Hong Kong, Macau and Singapore. With this agreement, Pfizer now holds global development and commercialization rights to the candidate, an orally administered fusion inhibitor is designed to block RSV replication by inhibiting F-mediated fusion with the host cell.
Read More
Infection

Japanese researchers discover quinolone derivatives for malaria

Dec. 19, 2022
No Comments
Nagasaki University and Shionogi & Co. Ltd. have described quinolone derivatives reported to be useful for the treatment of malaria.
Read More
Transmission electron microscopic image of varicella zoster virus.
Immune

Recbio's novel adjuvanted recombinant shingles vaccine REC-610 cleared to enter clinic in Philippines

Dec. 19, 2022
No Comments
Jiangsu Recbio Technology Co. Ltd. has received clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC-610, from the Food and Drug Administration of the Philippines. A phase I trial will be conducted in healthy volunteers.
Read More
Herpes simplex virus
Infection

Symbio enters sponsored research agreement to study brincidofovir in HSV-infected brain tissue model

Dec. 19, 2022
No Comments
Symbio Pharmaceuticals Ltd. has entered into a sponsored research agreement with Tufts University to conduct joint research on the intravenous formulation of the antiviral drug brincidofovir.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 1497 1498 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 3, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Feb. 3, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • Brain with clock hands, day and night background

    12-Hour as well as circadian brain rhythms disrupted in people with schizophrenia

    BioWorld Science
    Research shows that individuals with schizophrenia have abnormal gene expression patterns in their brains compared with people without the condition. In a study...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing